In�ammatory pseudotumor (IP) is a clinically aggressive but histologically benign condition of unknown cause. Its appearance in the temporal bone is uncommon. We present clinical, radiological, and histopathologic �ndings of three cases originating in the temporal bone. In the �rst case, a simultaneous IP of the temporal bone and parotid gland was found with histopathologic con�rmation. In the second case, an enlarged cervical node, which was also believed to be related to IP, was observed accompanied with the temporal lesion. While the third case presented with chronic suppurative otitis media. Two of them were treated by surgery alone with complete resolve of the diseases. Another one underwent tympanomastoidectomy in combination with oral steroids, radiation, and chemotherapy, but the IP still recurred. A comprehensive review of the literature on clinical features of the temporal pseudotumor was conducted.
Introduction
In�ammatory pseudotumor (IP), �rst described by �rich-Hirsh�eld in 1�05 and named by �miker et al. in 1�54, is a clinically invasive, yet histologically benign mass lesion of unknown etiology. It has a variety of histologic presentations and has been recognized under various names like plasma cell granuloma, in�ammatory myo�broblastic tumor, histiocytoma complex, xanthomatous pseudotumor, �brous xanthoma, and in�ammatory myo�brohistiocytic proliferation [1] . IP most commonly arises in the lung. Other sites include abdomen, retroperitoneum, or pelvis, upper respiratory tract, trunk, and extremities in descending order. Less than 5% of it occurs in the head and neck with orbit the most frequently involved site [1] .
IP of the temporal bone is uncommon but remains important given its recurrent and destructive natures. Only a limited number of these cases have previously been reported . Here, we present three new cases with variable manifestations. A comprehensive review of the English-speaking literature on clinical features of the temporal pseudotumor was performed for comparison.
Case Report
Case 1. In June 2008, an otherwise healthy 51-year-old man presented with le-sided ear fullness and hearing loss for a few days. He was diagnosed as otitis media with effusion and underwent a tympanocentesis plus oral antibiotics and steroids. e symptoms alleviated but returned with aggravated hearing and a new onset of otalgia one month later. Otoscopic and audiological examinations demonstrated intact tympanic membrane and severe mixed hearing loss of the involved ear. A computed tomographic (CT) scan revealed an erosive so-tissue mass of the le temporal bone extending into the sigmoid sinus (Figure 1(a) ). Magnetic resonance imaging (MRI) showed a slightly lowsignal-intensity lesion on T2-weighted images at the same location and several ipsilateral cervical nodes (Figure 1(b) ). A mastoidectomy was performed. During this procedure, in�amed tissue was found �lling the mastoid cavity and eroding into sigmoid sinus plate and the surrounding dura. Postoperative pathology was consistent with IP ( Figure 2(a) ), and immunohistochemical staining for and light-chains exhibited a polyclonal origin of plasma cells. A differential diagnosis was also made which excluded the possibility of neoplastic or granulomatous etiologies (plasmacytoma, Langenhans cell histiocytosis). During the patient's admission, he was noticed a swelling on his le parotid area and several enlarged lymph nodes in the upper neck. ey all shrunk dramatically aer tympanomastoidectomy without any other treatments.
During the 4-year follow-up period, the IP of the patient experienced three recurrences. e �rst recurrence occurred 6 months aer mastoidectomy, when he complained of progression of le parotid and neck swellings and underwent partial parotidectomy with lymphadenectomy at another hospital. e postoperative histology revealed that the in�ammatory in�ltrate of the parotid specimen was composed of �broblasts, lymphocytes, and plasma cells (Figure 2(b) ). e second recurrence came one month aer the parotidectomy. e patient reported le otalgia with new onsets of le-sided exophthalmos, orbital pain, diplopia, and headache. CT scan showed no gross mass in the orbit, but MRI revealed enhancing lesions in the le cerebellopontine area, cavernous sinus, temporal lobe meninges, and a suspicious involvement of cranial nerve. He was then commenced on a reducing regime of oral prednisone for 4 months accompanied by cyclophosphamide chemotherapy and radiotherapy. As we had expected, his otalgia, exophthalmos, diplopia, orbital pain, and headache were completely resolved. ereaer, the patient was well until he experienced a relapse of exophthalmos 16 months later (the third recurrence). A tapering steroid was prescribed again which subsequently relieved his symptom. Now the patient is still under followup and remains symptom free.
Case 2. e patient is a 44-year-old man who presented with intermittent le-sided otorrhea, otalgia, tinnitus, decreased hearing, and �uctuant neck swelling for 3 months. His medical history was unremarkable except for head trauma (fracture of the le temporal bone) one year prior to presentation. On physical examination, his le eardrum was intact but thickened, and a smooth cervical mass (enlarged lymph node) measuring 3 cm × 5 cm was palpable on the le. Audiological studies exhibited moderately mixed hearing loss of the involved ear. Temporal bone CT revealed a so-tissue mass in the le middle ear and mastoid cavity with bony erosion. MRI showed two nonhomogenous mass lesions in the le temporal bone and ipsilateral neck that was hypointensity on T2-weighted images (Figure 3 respectively. Complete blood cell count, blood chemistry, urinalysis, chest X-ray, and serologic test for syphilis, EBV, CMV, and HIV were generally normal. e patient was then planned for a tympanomastoidectomy both for diagnosis and treatment. Intraoperatively, the middle ear and mastoid cavity were found �lling with the pinkish neoplasm which encased the vertical segment of the facial nerve. e surgical margin between the neoplasm and normal tissues was vague. Extensive bony erosion was seen in the plates of sigmoid sinus, superior petrosal sinus, tegmen tympani, and posterior cranial fossa. Postoperative histopathology of the surgical specimen revealed characteristic of IP (Figure 4(a) ). Further immunohistochemical staining exhibited CD38 (++), CD3 (+), CD20 (+), CK (+), (+), (+), and SMA (−) (Figures 4(b) , 4(c), and 4(d)). Similar to that of the �rst case, the neck mass in this patient disappeared soon aer the mastoid surgery. During our 14-month followup, the patient was well although additional treatment was not performed.
Case 3.
A 50-year-old male was admitted to our hospital with a 7-year history of intermittent otorrhea and decreased hearing in the le ear. He denied tinnitus or vertigo. His medical history was otherwise unremarkable. Otoscopic and audiological examinations revealed a small perforation at the �accid part of tympanic membrane and a moderate conductive hearing loss on the le. CT scans of the temporal bone showed opaci�cation of epitympanum and mastoid antrum with erosion of malleal head and incus of the involved ear ( Figure 5 ). With the initial diagnosis of chronic suppurative otitis media, a canal-wall down mastoidectomy with tympanoplasty was performed. Intraoperatively, it was found that the hyperplastic so tissue �lled both the mastoid antrum and epitympanum, which was removed completely without difficulty. ere was no erosion of the tegmen, and the middle ear cavity was free of disease. e postoperative course was uneventful. A histopathological exam showed proliferation of �broblast with in�l-tration of numerous plasma cells and lymphocytes, and immunohistochemical staining for and light-chains also exhibited a polyclonal origin of plasma cells. eses features were consistent with an IP. e patient's mastoid cavity healed well, and there was no evidence of recurrence for 11-month followup.
Literature Review
Pseudotumor of the temporal bone is an unusual condition. According to the literatures searched in the Pubmed database from 1970 to the present using the medical subject headings �in�ammatory pseudotumor/plasma cell granuloma/in�ammatory myo�broblastic tumor" and �temporal bone/middle ear/mastoid/facial nerve, " only 29 evaluable cases were identi�ed (Table 1) . ere are seventeen men and twelve women, with an average age of 38.0 years (median age, 39.0 years; range, 2.5-75 years). e presenting symptoms are mainly hearing loss (20/29) , otalgia (12/29), otorrhea (10/29), facial palsy (7/29), and dizziness/vertigo (5/29). Complains of tinnitus, ear fullness, headache, retrobulbar pain, diplopia, facial pain, and visual dimness are all uncommon. e mastoid and middle ear are the most frequent sites involved, representing 86.2% (25/29) and 75.9% (22/29) of reported cases, respectively. However, temporal pseudotumor appears to have a more aggressive and unpredictable courses than IPs in other body sites. IPs occurring in the middle ear and mastoid may erode into the surrounding dura, sigmoid sinus, tentorium, and even brain parenchyma [7, 9-11, 15, 16] . Intratemporal extensions to the otic capsule, facial nerve, petrous apex, and internal auditory canal are common [6, 8, 10, 14, 21] .
IPs is usually isolated. ere is only one case had a concomitant IP of the temporal bone and lung [13] , and three had indirect orbit involvement [4, 11, 13] . As for treatments, surgery is usually of the �rst priority, occurring in 24 reported cases (82.8%). e outcomes are some different among patients: two died of the disease progression soon aer the diagnosis [8, 21] , two experienced spontaneous improvement without any treatment [18, 22] , and the others had subsequently complete or partial remission during the follow up period. Recurrent disease occurred in three of the twenty nine cases (10.3%), and all of them relapsed within a few months aer treatment [6, 8, 19 ].
Discussion
IP most commonly involves the lung and orbit, but it has been described in almost any location, in both sexes, at all ages [1, 10] . It is characterized by the presence of a mass lesion that may mimic malignancy and that is composed of spindle cells mixed with variable amounts of extracellular collagen, lymphocytes, and plasma cells [25, 26] . e pathogenesis of IP is still obscure but immunological and infectious causes have been postulated [10, 27] . Recently, some IPs have been found to be associated with IgG4-related sclerosing diseases [28, 29] , and Masterson et al. [28] recommended a full review of all histological specimens in patients with a diagnosis of IP or in�ammatory myo�broblastic tumor. Consideration should be given to staining for IgG4, together with measurement of serum levels. In our �rst patient, the �uctuant swelling of the parotid area and lymph nodes may suggest a nonspeci�c autoimmune response, while recurrent exophthalmos in the absence of orbit mass may caused by venous obstruction since tumor was noted within the cavernous sinus. For Cases 2 and 3, however, a posttraumatic or postinfectious in�ammatory Yanagihara et al. [2] 41/M Recurrent FP ME/facial nerve Surg NED Benton et al. [3] 37/M Ota ME/M Surg/Radio NED at 1 yr Nam et al. [4] 24/F Ota/HL/Dizz/RP M/dura Surg/Radio NED at 1 yr Wiseman et al. [5] 4/M FP ME/M/facial nerve Surg NED 39/M HL ME/M/Lab/IAC Surg NED Mulder et al. [6] 38/F HL ME/M/Lab/IAC Surg NED 50/F HL ME/M/Lab/IAC Surg Relapsed Janicki et al. [7] 55/M Oto/Tinn/vertigo ME/M/dura/petrous apex Radio NED at 2 mo 39/F Ota/Oto/vertigo/HL ME/M Surg/steroid/IST Relapsed at 4 mo Schönermark [8] 49/F Ota/Oto/HL ME/M/Lab Surg/steroid NED at 30 mo 35/F FP/HL/Ota/Oto ME/M/Lab Surg/IST NED at 2 yrs 59/M Ota/Oto/HL ME/M/Lab Surg/IST/steroid Died of the disease Gasparotti et al. [9] 26/M Vertigo M/Teg/Sig/dura Surg NED Williamson et al. [10] 49/M HL/Oto ME/M/Teg/MCF/Lab Surg/steroid NED at 6 mo Cho et al. [11] 42/F Hea/HL/FP/diplopia/ visual dimness M/ME/dura/tentorium/ cavernous sinus Steroid Remission at 3 mo Cho et al. [12] 55/F HL/Oto ME/M Surg NED at 1 yr Lee et al. [13] 39/M HL/RP/diplopia M/petrous apex/lung Surg/steroid NED at 1 yr Lee et al. [14] 28 [20] 2.5/M Ota/�uctuating FP ME/M/Lab Surg/steroid NED at 1.5 yrs Santaolalla-Montoya et al. [21] 75/M Hea/Oto/HL ME/M/Petrous apex/dura Surg/steroid Died of the disease Galindo et al. [22] 28/M HL/Hea/Ota Petrous apex/ME No Remission at 3 yrs Goh et al. [23] 27/F Ota/HL ME/M (bilateral) Surg/steroid NED at 3 yrs Vasileios et al. [24] 19/M auricular polyp ME/External ear Surg NED at 6 mo Ota: otalgia; HL: hearing loss; Dizz: dizziness; Tinn: tinnitus; RP: retrobulbar pain; Oto: otorrhea; Hea: headache; FP: facial palsy; Exo: exophthalmos; ME: middle ear; M: mastoid; Lab: labyrinth; Teg: tegmen tympani; MCF: middle cranial fossa; Sig: sigmoid sinus; IAC: internal auditory canal; Surg: surgery; Radio: radiotherapy; IST: immunosuppressive therapy; NED: no evidence of disease at followup.
process should be considered. But it's a pity we didn't do IgG4 test in all our cases. e diagnosis of temporal pseudotumor is one of exclusion based on history, clinical examination, radiological tests, and especially histopathology. Clinical manifestations vary widely among cases as indicated by our and previous reports. Laboratory abnormalities include anemia, thrombocytosis, polyclonal hypergammaglobulinemia, and elevated ESR, CRP, or IgG4 [1, 28] . CT scan usually shows erosive so-tissue mass in the middle ear and/or mastoid with occasional extensions into adjacent structures. Common MRI �ndings are low-signal intensity on T2-weighted images and homogeneous contrast enhancement [15, 26] . All these features, however, are not very speci�c. us, a diagnosis can only be made with histopathologic and immunohistochemical studies [1, 10] , especially the latter one. Pseudotumor of the temporal bone usually occurs in isolation and involves one ear according to the literature review. To the best of our knowledge, the appearance of simultaneous lesions of the temporal bone and parotid gland has not been reported previously. us, Case 1 in our series may represent the �rst such reported case with pathological con�rmation. In addition, the ipsilateral neck masses (enlarged lymph nodes) in the �rst two patients may also associate with the temporal bone lesions as both of them shrunk immediately aer mastoid surgery, even though there was a lack of solid proof.
Treatments for temporal pseudotumor are controversial with excision, corticosteroid, radiotherapy, chemotherapy, or any combinations of the four depending on tumor location, behavior, and the condition of the patient . Surgery is usually of the �rst priority. �ther options have been used primarily as an adjuvant to surgery or for those with inadequate excision or recurrent disease. While Coulson et al. [16] suggest a trial of oral steroids prior to surgery, as this alone may completely resolve the patients' symptoms. e steroid regimen is oen given according to doctors' experience [10, 11, 13, 16, 19] , and a course of high-dose oral steroids followed by tapering is usually chosen. We cannot draw conclusions from few cases about which regimen to be the best, but we suggest further studies to reach an agreement about the type and course of the steroid therapy.
e prognosis of IP is usually good. As far as our three patients are concerned, the outcomes are much different. In two cases treated by surgery alone, the diseases resolved completely. While the IP of the �rst case experienced several recurrences during followup, even though a combined modality therapy of surgery, steroid, radiotherapy and chemotherapy was chosen. is may due to the variable natural history of IP, the in�ltrative and recurrent nature of focal lesion, or because of the insufficient steroid course used.
Conclusion
IP of the temporal bone is rare. It has no distinctive characteristics both clinically and radiologically, and the presenting symptoms and biological behaviors vary widely among patients. In this paper, we present three new cases of temporal pseudotumor with variable clinical manifestations and treatment outcomes. In two of them, a possible involvement of cervical lymph node and/or concomitant IP of the parotid gland were found. To the authors' knowledge, our �rst patient represents the only reported case so far to have a simultaneous appearance of IPs both in the temporal bone and in the parotid gland.
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